Met Life Investment Management, LLC Pep Gen Inc. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Pep Gen Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 9,420 shares of PEPG stock, worth $38,810. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,420
Previous 9,420
-0.0%
Holding current value
$38,810
Previous $150,000
46.67%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PEPG
# of Institutions
60Shares Held
25.2MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA10.7MShares$44 Million1.27% of portfolio
-
Janus Henderson Group PLC London, X02.34MShares$9.63 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY1.66MShares$6.84 Million0.56% of portfolio
-
Viking Global Investors LP1.48MShares$6.11 Million0.05% of portfolio
-
Perceptive Advisors LLC New York, NY1.41MShares$5.81 Million0.32% of portfolio
About PepGen Inc.
- Ticker PEPG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,631,900
- Market Cap $97.4M
- Description
- PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...